Slovenia's national cancer centre, OECI-accredited, home of one of Europe's oldest cancer registries and a pioneer of electrochemotherapy.
Founded in 1938, the Institute of Oncology Ljubljana is Slovenia's only comprehensive cancer centre and is accredited by the OECI. It hosts the Cancer Registry of Republic of Slovenia, established in 1950 as one of the earliest population-based registries in Europe, and runs the national screening programmes. Gregor Serša and Maja Čemažar's group pioneered electrochemotherapy, combining electric pulses with bleomycin or cisplatin, and the institute led the European ESOPE standard operating procedures; it also has strong programmes in melanoma, breast and head and neck cancer, radiotherapy and brachytherapy, and medical oncology trials. The institute serves as the teaching base for oncology at the University of Ljubljana.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Institute of Oncology Ljubljana, including child institutions. 187 works · 2,566 citations · 82% open access · 8% clinical trials · 2% reviews.
Medical oncologist and Medical Director of the Institute of Oncology Ljubljana, with research in melanoma and colorectal cancer.
Director of the Institute of Oncology Ljubljana, Slovenia's national comprehensive cancer centre.
Shares Brachytherapy, Organisation of European Cancer Institutes, Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam).
Shares Brachytherapy, HPV & HBV vaccination, Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam).
Shares Brachytherapy, HPV & HBV vaccination, Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam).
Shares Brachytherapy, Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.
Shares Brachytherapy, Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.
Shares Brachytherapy, Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.
Shares Irreversible electroporation (NanoKnife), Head and neck squamous cell carcinoma, Melanoma.
Shares Brachytherapy, HPV & HBV vaccination, Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer.